{"id":"https://openalex.org/W2124560587","doi":"https://doi.org/10.1021/bc800289a","title":"Novel Peptide Linkers for Highly Potent Antibody\u2212Auristatin Conjugate","display_name":"Novel Peptide Linkers for Highly Potent Antibody\u2212Auristatin Conjugate","publication_year":2008,"publication_date":"2008-09-20","ids":{"openalex":"https://openalex.org/W2124560587","doi":"https://doi.org/10.1021/bc800289a","mag":"2124560587","pmid":"https://pubmed.ncbi.nlm.nih.gov/18803412"},"language":"en","primary_location":{"id":"doi:10.1021/bc800289a","doi":"https://doi.org/10.1021/bc800289a","is_oa":false,"landing_page_url":"https://doi.org/10.1021/bc800289a","pdf_url":null,"source":{"id":"https://openalex.org/S155115410","display_name":"Bioconjugate Chemistry","issn_l":"1043-1802","issn":["1043-1802","1520-4812"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioconjugate Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103551444","display_name":"Svetlana O. Doronina","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Svetlana O. Doronina","raw_affiliation_strings":["Seattle Genetics, Incorporated, 21823 30th Drive SE, Bothell, Washington 98021","Seattle Genetics, Inc., 21823 30th Drive SE, Bothell, Washington 98021, USA. sdoronina@seagen.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle Genetics, Incorporated, 21823 30th Drive SE, Bothell, Washington 98021","institution_ids":["https://openalex.org/I99319750"]},{"raw_affiliation_string":"Seattle Genetics, Inc., 21823 30th Drive SE, Bothell, Washington 98021, USA. sdoronina@seagen.com","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067420985","display_name":"Tim D. Bovee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tim D. Bovee","raw_affiliation_strings":["Seattle Genetics, Incorporated, 21823 30th Drive SE, Bothell, Washington 98021"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle Genetics, Incorporated, 21823 30th Drive SE, Bothell, Washington 98021","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031507153","display_name":"David W. Meyer","orcid":"https://orcid.org/0000-0002-2864-3935","observed_orcids":["https://orcid.org/0000-0002-2864-3935"]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David W. Meyer","raw_affiliation_strings":["Seattle Genetics, Incorporated, 21823 30th Drive SE, Bothell, Washington 98021"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle Genetics, Incorporated, 21823 30th Drive SE, Bothell, Washington 98021","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045436281","display_name":"Jamie B. Miyamoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jamie B. Miyamoto","raw_affiliation_strings":["Seattle Genetics, Incorporated, 21823 30th Drive SE, Bothell, Washington 98021"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle Genetics, Incorporated, 21823 30th Drive SE, Bothell, Washington 98021","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046639473","display_name":"Martha E. Anderson","orcid":"https://orcid.org/0009-0006-5235-1904","observed_orcids":["https://orcid.org/0009-0006-5235-1904"]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martha E. Anderson","raw_affiliation_strings":["Seattle Genetics, Incorporated, 21823 30th Drive SE, Bothell, Washington 98021"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle Genetics, Incorporated, 21823 30th Drive SE, Bothell, Washington 98021","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073992829","display_name":"Carol A. Morris-Tilden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carol A. Morris-Tilden","raw_affiliation_strings":["Seattle Genetics, Incorporated, 21823 30th Drive SE, Bothell, Washington 98021"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle Genetics, Incorporated, 21823 30th Drive SE, Bothell, Washington 98021","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089318759","display_name":"Peter D. Senter","orcid":"https://orcid.org/0000-0003-2748-6007","observed_orcids":["https://orcid.org/0000-0003-2748-6007"]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter D. Senter","raw_affiliation_strings":["Seattle Genetics, Incorporated, 21823 30th Drive SE, Bothell, Washington 98021"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle Genetics, Incorporated, 21823 30th Drive SE, Bothell, Washington 98021","institution_ids":["https://openalex.org/I99319750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5103551444"],"corresponding_institution_ids":["https://openalex.org/I99319750"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":2.8116,"has_fulltext":false,"cited_by_count":182,"citation_normalized_percentile":{"value":0.90628136,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"19","issue":"10","first_page":"1960","last_page":"1963"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.8984000086784363,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.8984000086784363,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.02850000001490116,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.02539999969303608,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9860000014305115},{"id":"https://openalex.org/keywords/auristatin","display_name":"auristatin","score":0.9750000238418579},{"id":"https://openalex.org/keywords/monomethyl-auristatin-e","display_name":"monomethyl auristatin E","score":0.8420000076293945},{"id":"https://openalex.org/keywords/peptide-linkers","display_name":"peptide linkers","score":0.9229999780654907},{"id":"https://openalex.org/keywords/c-terminal-amino-acids","display_name":"C-terminal amino acids","score":0.5630000233650208},{"id":"https://openalex.org/keywords/therapeutic-index","display_name":"therapeutic index","score":0.6380000114440918},{"id":"https://openalex.org/keywords/antimitotic-agents","display_name":"antimitotic agents","score":0.6399999856948853}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9736676812171936},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.8833155632019043},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.6597768664360046},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5193718075752258},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.515584409236908},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3367680311203003},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2435280680656433},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.08261522650718689},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009842","descriptor_name":"Oligopeptides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050256","descriptor_name":"Antimitotic Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1021/bc800289a","doi":"https://doi.org/10.1021/bc800289a","is_oa":false,"landing_page_url":"https://doi.org/10.1021/bc800289a","pdf_url":null,"source":{"id":"https://openalex.org/S155115410","display_name":"Bioconjugate Chemistry","issn_l":"1043-1802","issn":["1043-1802","1520-4812"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioconjugate Chemistry","raw_type":"journal-article"},{"id":"pmid:18803412","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18803412","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioconjugate chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.5683000087738037}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1557340160","https://openalex.org/W1955007080","https://openalex.org/W1963995456","https://openalex.org/W1965084153","https://openalex.org/W1977230486","https://openalex.org/W1977241343","https://openalex.org/W2023034663","https://openalex.org/W2024023279","https://openalex.org/W2030177226","https://openalex.org/W2061393217","https://openalex.org/W2079154601","https://openalex.org/W2083670340","https://openalex.org/W2088964247","https://openalex.org/W2090057677","https://openalex.org/W2131478662","https://openalex.org/W2136101268","https://openalex.org/W2156506990"],"related_works":["https://openalex.org/W3021217940","https://openalex.org/W2090057677","https://openalex.org/W2136101268","https://openalex.org/W7170132303","https://openalex.org/W2029213978","https://openalex.org/W2962021985","https://openalex.org/W3007430974","https://openalex.org/W2570610348","https://openalex.org/W4391616985","https://openalex.org/W2501205265"],"abstract_inverted_index":{"Auristatins":[0],"are":[1],"highly":[2,213],"potent":[3,214],"antimitotic":[4],"agents":[5],"that":[6,52,195],"have":[7],"received":[8],"considerable":[9],"attention":[10],"because":[11],"of":[12,23,32,42,87,95,123,138,197],"their":[13,102],"activities":[14],"when":[15],"targeted":[16],"to":[17,37,104,164,203,206,212],"tumor":[18],"cells":[19,107],"in":[20,154],"the":[21,33,38,78,83,88,93,121,142,146,165,188,198,207],"form":[22],"antibody-drug":[24],"conjugates":[25,217],"(ADCs).":[26],"Our":[27],"lead":[28,211],"agent,":[29],"SGN-35,":[30],"consists":[31],"cAC10":[34],"antibody":[35],"linked":[36],"N-terminal":[39],"amino":[40,79],"acid":[41,80],"monomethylauristatin":[43,71],"E":[44],"(MMAE)":[45],"via":[46],"a":[47,135],"valine-citrulline":[48],"p-aminobenzylcarbamate":[49],"(val-cit-PABC)":[50],"linker":[51,124],"is":[53,99,108],"cleaved":[54],"by":[55,115,133,176],"intracellular":[56],"proteases":[57],"such":[58],"as":[59,187],"cathepsin":[60],"B.":[61],"More":[62],"recently,":[63],"we":[64,119],"developed":[65],"an":[66],"auristatin":[67],"F":[68,72],"(AF)":[69],"derivative":[70],"(MMAF),":[73],"which":[74],"unlike":[75],"MMAE":[76],"contains":[77],"phenylalanine":[81],"at":[82],"C-terminal":[84,91,143,189,199],"position.":[85],"Because":[86],"negatively":[89],"charged":[90],"residue,":[92],"potency":[94],"AF":[96],"and":[97,131,145,215],"MMAF":[98],"impaired.":[100],"However,":[101],"ability":[103],"kill":[105],"target":[106],"greatly":[109,219],"enhanced":[110],"through":[111],"facilitated":[112],"cellular":[113],"uptake":[114],"internalizing":[116],"mAbs.":[117],"Here,":[118],"explore":[120],"effects":[122],"technology":[125],"on":[126],"AF-based":[127],"ADC":[128],"potency,":[129],"activity,":[130,155],"tolerability":[132],"generating":[134,177],"diverse":[136],"set":[137],"dipeptide":[139],"linkers":[140],"between":[141],"residue":[144],"mAb":[147,208],"carrier.":[148],"The":[149,169],"resulting":[150],"ADCs":[151,179],"differed":[152],"widely":[153],"with":[156,183,218],"some":[157],"having":[158],"significantly":[159],"improved":[160,220],"therapeutic":[161,170,221],"indices":[162],"compared":[163],"original":[166],"mAb-Val-Cit-PABC-MMAF":[167],"conjugate.":[168],"index":[171],"was":[172],"increased":[173],"yet":[174],"further":[175],"dipeptide-based":[178],"utilizing":[180],"new":[181],"auristatins":[182,205],"methionine":[184],"or":[185],"tryptophan":[186],"drug":[190],"residue.":[191],"These":[192],"results":[193],"demonstrate":[194],"manipulation":[196],"peptide":[200],"sequence":[201],"used":[202],"attach":[204],"carrier":[209],"can":[210],"specific":[216],"windows.":[222]},"counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":15},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":16},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":14},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":13},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}